check_circleStudy Completed

Primary pulmonary hypertension

Bayer Identifier:

15762

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2012-000119-10

EU CT Number:

Not Available
Ventavis 20:PK compared with Ventavis 10 in healthy subjects

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
21
Trial Dates
May 2012 - June 2012
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Ventavis (Iloprost, BAYQ6256)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer Pharma AGBerlin, 13353, Germany

Trial design

A randomized, open-label, single center, crossover study to compare the pharmacokinetics of iloprost following inhalation of Ventavis 10 or Ventavis 20 solution with the I-Neb™ nebulizing device in healthy male volunteers under the condition of an extended inhalation time
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.